Morton Dl - Concepedia

Author

Morton Dl

Saint John's Health Center

Also Known As

D L Morton, DL MORTON, DL Morton, Morton Dl

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Saint John's Health Center University of California, Los Angeles

About

Morton Dl is an author at Saint John's Health Center specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	997
2	Health Sciences	1	1	15
3	Cell Biology	1	1	73
4	Cellular Therapies	1	1	73
5	Hepatology	1	1	15

Morton Dl

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Demonstration of antibodies against human malignant melanoma by immunofluorescence. Morton Dl, Malmgren Ra, Holmes Ec, PubMed Tumor ImmunologyMelanomaImmunologyTumor ImmunityHuman Malignant Melanoma	1968	388
Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms. Bilchik Aj, A E Giuliano, Richard Essner, PubMed	1999	180
The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: a preliminary study. Fee Hj, Robinson Ds, Sample Wf, Munich Personal RePEc Archive (Ludwig Maximilian University of Munich)	1978	137
Immunologic and virus studies with human sarcomas. Morton Dl, Malmgren Ra, Hall Wt, PubMed ImmunologyVirologyVirus StudiesMedicineViral Oncology	1969	98
Production of melanoma-associated antigen(s) by a defined malignant melanoma cell strain grown in chemically defined medium. Chee Do, Boddie Aw, Roth Ja, PubMed Cell TherapyImmunologyBlood CellImmunoeditingCell Culture	1976	73
Human leukocyte (alpha) interferon in metastatic malignant melanoma: the American Cancer Society phase II trial. Krown Se, Burk Mw, Kirkwood Jm, PubMed Cancer ImmunosurveillanceMetastatic Malignant MelanomaPartial ResponseMedicineMelanoma	1984	64
Lymphatic mapping and sentinel lymphadenectomy for melanoma: past, present, and future. Morton Dl PubMed Surgical OncologySentinel LymphadenectomyMedicineLymphatic MappingMelanoma	2001	55
Immunosuppression by melanoma cells as a factor in the generation of metastatic disease. Cochran Aj, Wen Dr, Zohreh Farzad, PubMed ImmunologyDermatologyImmunotherapyMelanoma CellsTumor Immunology	1989	52
Intraoperative lymphatic mapping and sentinel lymphadenectomy: community standard care or clinical investigation? Morton Dl PubMed Intraoperative Lymphatic MappingSentinel LymphadenectomySurgical PathologyLymphatic SystemSurgery	1998	47
Vaccine therapy for patients with melanoma. Haigh Pi, Difronzo La, Guy Gammon, PubMed ImmunologyImmunoeditingVaccine TherapyImmune Cell TherapyImmunotherapy	1999	39

Page 1